Associations between environmental factors and incidence of cutaneous melanoma. Review

Environmental Health: A Global Access Science Source

Volumn 11, Issue SUPPL.1, 2012, Pages

  Volkovova, Katarina ^a   Bilanicova, Dagmar ^a,b   Bartonova, Alena ^c   Letaiová, Silvia ^d   Dusinska, Maria ^a,c  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^b CA' FOSCARI UNIVERSITY OF VENICE   (Italy)

^c NORWEGIAN INSTITUTE FOR AIR RESEARCH   (Norway)

^d SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOIC ACID; 4 AMINOBENZOIC ACID ESTER; ANTIOXIDANT; AVOBENZONE; CALCITRIOL; CINNAMIC ACID DERIVATIVE; COLECALCIFEROL; CYCLIN DEPENDENT KINASE 4; DNA; DROMETRIZOLE; ESTRADIOL; ESTROGEN; EUMELANIN; FOLIC ACID; MELANIN; PHEOMELANIN; PROGESTERONE; REACTIVE OXYGEN METABOLITE; SALICYLIC ACID DERIVATIVE;

BIOMARKER; CANCER; DATABASE; DISEASE INCIDENCE; ENVIRONMENTAL FACTOR; ETIOLOGY; HEALTH RISK; LIFESTYLE; LITERATURE REVIEW; MELANISM; PATHOGENICITY; PUBLIC HEALTH; TEMPORAL ANALYSIS;

CANCER INCIDENCE; CANCER RISK; CHLOASMA; CUTANEOUS MELANOMA; DISEASE ASSOCIATION; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EXCISION REPAIR; FAMILY HISTORY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; HYPERPIGMENTATION; IONIZING RADIATION; LATITUDE; LIFESTYLE; MALIGNANT TRANSFORMATION; MELANOCYTE; PHOTOLYSIS; PREGNANCY; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REVIEW; SEX DIFFERENCE; SUNBURN; SYSTEMATIC REVIEW; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; GENETICS; INCIDENCE; MELANOMA; RISK FACTOR; SKIN TUMOR;

SCOPUS;

HUMANS; INCIDENCE; MELANOMA; RISK FACTORS; SKIN NEOPLASMS;

EID: 84863305829     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-11-S1-S12     Document Type: Review

References (165)

1. The mechanisms of UV radiation in the development of malignant melanoma. Situm M, Buljan M, Buli SO, Simi D, Coll Antropol 2007 1 13 16
2. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Chang AE, Karnell LH, Menck HR, Cancer The American College of Surgeons Commission on Cancer and the American Cancer Society 1998 83 1664 1678 10.1002/(SICI)1097-0142(19981015)83: 8<1664::AID-CNCR23>3.0.CO;2-G 9781962 (Pubitemid 28465486)
3. In vitro transformation of human congenital naevus to malignant melanoma. Mehta RR, Bratescu L, Graves JM, Shilkaitis A, Green A, Mehta RG, Das Gupta TK, Melanoma Research 2002 12 27 33 10.1097/00008390-200202000-00005 11828255 (Pubitemid 34183686)
4. Melanoma: etiology, treatment, and dental implications. Little JW, Gen Dent 2006 54 61 66 16494125 (Pubitemid 43266259)
5. Clinical dermatology: a color guide to diagnosis and therapy. Habif TP, St. Louis: Mosby 3rd 1996 714 715
6. Malignant Transformation of Melanocytes to Melanoma by Constitutive Activation of Mitogen-activated Protein Kinase Kinase (MAPKK) Signaling. Govindarajan B, Bai X, Cohen C, Zhong H, Kilroy S, Louis G, Moses M, Arbiser JL, The J Biol Chem 2003 278 9790 9795 10.1074/jbc.M212929200 (Pubitemid 36800479)
7. Malignant Melanoma: It Pays to Be a Woman. Brenner S, Mashiah J, SKINmed 2003 2 183 187 10.1111/j.1540-9740.2003.01819.x 14673297
8. Role of sun exposure in melanoma. Ivry GB, Ogle CA, Shim EK, Dermatol Surg 2006 32 481 492 10.1111/j.1524-4725.2006.32101.x 16681655
9. Long-term health risk to the skin of ultraviolet radiation. MacKie RM, Prog Biophys Mol Biol 2006 92 92 96 10.1016/j.pbiomolbio.2006.02.008 16616325 (Pubitemid 43831961)
10. Toxic effects of ultraviolet radiation on the skin. Matsumu Y, Ananthaswamy HN, Toxicol Appl Pharmacol 2004 195 298 308 10.1016/j.taap.2003.08. 019 15020192 (Pubitemid 38338650)
11. UV-radiation - sources, wavelength, environment. Hölzle E, Hönigsmann H, J Dtsch Dermatol Ges 2005 3 Suppl 2 3 10 16117741
12. Changes in biologically active ultraviolet radiation reaching the Earths surface. Madronich S, McKenzie RL, Björn LO, Caldwell MM, J Photochem Photobiol B 1998 46 5 19 10.1016/S1011-1344(98)00182-1 9894350 (Pubitemid 29017147)
13. How sunlight causes melanoma. Garibyan L, Fisher DE, Curr Oncol Rep 2010 12 319 326 10.1007/s11912-010-0119-y 20623386
14. Signaling by reactive oxygen and nitrogen species in skin diseases. Afanas'ev IB, Curr Drug Metab 2010 11 409 414 10.2174/138920010791526060 20540699
15. Health risks. Longstreth J, de Gruijl FR, Kripke ML, Abseck S, Arnold F, Slaper HI, Velders G, Takizawa Y, van der Leun JC, J Photochem Photobiol B: Biol 1998 46 20 39 10.1016/S1011-1344(98)00183-3 (Pubitemid 29017148)
16. DNA/RNA nucleotides and nucleosides: direct measurement of excited-state lifetimes by femtosecond fluorescence up-conversion. Peon J, Zewail AH, Chem Phys Lett 2001 348 255 262 10.1016/S0009-2614(01)01128-9 (Pubitemid 33630861)
17. Chromophores in human skin. Young AR, Phys Med Biol 1997 42 789 802 10.1088/0031-9155/42/5/004 9172259 (Pubitemid 27263500)
18. DNA Excited-State Dynamics: Ultrafast Internal Conversion and Vibrational Cooling in a Series of Nucleosides. Pecourt JML, Peon J, Kohler B, J Am Chem Soc 2001 123 10370 10378 10.1021/ja0161453 11603988 (Pubitemid 32979787)
19. Ultrafast internal conversion of electronically excited RNA and DNA nucleosides in water. Pecourt JML, Peon J, Kohler B, J Am Chem Soc 2000 122 9348 9349 10.1021/ja0021520
20. The IFPCS presidential lecture: a chemists view of melanogenesis. Ito S, Pigment Cell Res 2003 16 230 236 10.1034/j.1600-0749.2003.00037.x 12753395 (Pubitemid 36597062)
21. The evolution of human skin coloration. Jablonski NG, Chaplin G, J Hum Evol 2000 39 57 106 10.1006/jhev.2000.0403 10896812 (Pubitemid 30480792)
22. Radiative Relaxation Quantum Yields for Synthetic Eumelanin. Meredith P, Riesz J, Photochem Photobiol 2004 79 211 216 10.1562/0031-8655(2004)079<0211: RCRQYF>2.0.CO;2 15068035
23. Expression profiling of human keratinocyte response to ultraviolet A: implications in apoptosis. He YY, Huang JL, Sik RH, Liu J, Waalkes MP, Chignell CD, J Invest Dermatol 2004 122 533 43 10.1046/j.0022-202X.2003.22123.x 15009741 (Pubitemid 38281080)
24. UV transmission measurements of small skin specimens with special quartz cuvettes. Hoffmann K, Kaspar K, Altmeyer P, Gambichler T, Dermatology 2000 201 307 311 10.1159/000051543 11146339 (Pubitemid 32037556)
25. High Gene Mutation Rate May Contribute to Hereditary Skin Cancers. Eskandarpour M, Hashemi J, Kanter L, J Natl Cancer Inst 2003 95 790
26. Mutations of the BRAF gene in human cancer. Davies H, Bignell GR, Cox C, Nature 2002 417 949 954 10.1038/nature00766 12068308 (Pubitemid 34716871)
27. Erythema And Melanogenesis Action Spectra Of Normal Human Skin. Parrish JA, Kurt F, Jaenicke R, Rox A, Photochem Photobiol 1982 36 187 191 10.1111/j.1751-1097.1982.tb04362.x 7122713 (Pubitemid 12037234)
28. Mutation In Metastatic Melanomas And Primary Melanomas From Sun-Exposed And Sun-Protected Sites. Li G, Ho VC, Trotter MJ, Horsman DE, Tron VA, J Eur Acad Dermatol Venereol 1995 4 48 53
29. The Molecular Perspective: Ultraviolet Light and Pyrimidine Dimers. Goodsell DS, The Oncologist 2001 6 298 299 10.1634/theoncologist.6-3-298 11423677 (Pubitemid 32592222)
30. DNA repair and mutagenesis. Friedberg EC, Walker GC, Siede W, Wood RD, Schultz RA, Ellenberger T, ASM Press 2nd 2006 1118 1120
31. Effect of photoreactivating light on UV radiation-induced alterations in human skin. Whitmore SE, Potten CS, Chadwick CA, Strickland PT, Morison WL, Photodermatol Photoimmunol Photomed 2001 17 213 217 10.1034/j.1600-0781.2001. 170502.x 11555330 (Pubitemid 32834285)
32. Establishment and characterization of a monoclonal-antibody recognising the Dewar isomers of (6-4) photoproducts. Matsunaga T, Hatakeyama Y, Ohta M, Mori T, Nikaido O, Photochem Photobiol 1993 57 934 940 10.1111/j.1751-1097.1993. tb02952.x 8367534
33. The use of specific radioimmunoassays to determine action spectra for the photolysis of (6-4) photoproducts. Mitchell DL, Rosenstein BS, Photochem Photobiol 1987 45 781 786 10.1111/j.1751-1097.1987.tb07882.x 3628501
34. Singlet Oxygen Generation by UVA Light Exposure of Endogenous Photosensitizers. Baier J, Maisch T, Maier M, Engel E, Landthaler M, Bäumler W, Biophys J 2006 91 1452 1459 10.1529/biophysj.106.082388 16751234 (Pubitemid 44174262)
35. Oxidative stress, caloric restriction, and aging. Sohal RS, Weindruch R, Science 1996 273 59 63 10.1126/science.273.5271.59 8658196 (Pubitemid 26255420)
36. Epidermal trans-urocanic acid and the UV-A-induced photoaging of the skin. Hanson KM, Simon JD, Proc Natl Acad Sci USA 1998 95 10576 10578 10.1073/pnas.95.18.10576 9724745 (Pubitemid 28413109)
37. Photochemical reactions and phototoxicity of sterols: novel self-perpetuating mechanisms for lipid photooxidation. Albro PW, Bilski P, Corbett JT, Schroeder JL, Chignell CF, Photochem Photobiol 1997 66 316 325 10.1111/j.1751-1097.1997.tb03154.x 9297976 (Pubitemid 127494521)
38. 3-Hydroxypyridine Chromophores Are Endogenous Sensitizers of Photooxidative Stress in Human Skin Cells. Wondrak GT, Roberts MJ, Jacobson MK, Jacobson EL, J Biol Chem 2004 279 30009 30020 10.1074/jbc.M404379200 15133022 (Pubitemid 38937921)
39. (Pheo)Melanin Photosensitizes UVA-Induced DNA Damage in Cultured Human Melanocytes. Wenczl E, van der Schans GP, Roza L, Kolb RM, Timmerman AJ, Smit NPM, Pavel S, Schothorst AA, J Investig Dermatol 1998 111 678 682 10.1046/j.1523-1747.1998.00357.x 9764853 (Pubitemid 28452333)
40. Tryptophan as an endogenous photosensitizer to elicit harmful effects of ultraviolet B. Babu V, Joshi PC, Indian J Biochem Biophys 1992 29 296 298 1324884
41. Singlet oxygen-induced DNA damage. Defedericis HC, Patrzyc HB, Rajecki MJ, Budzinski EE, Lijima H, Dawidzik JB, Evans MS, Greene KE, Box HC, Radiat Res 2006 165 445 451 10.1667/RR3533.1 16579657
42. Oxidative stress in environmental-induced carcinogenesis. Mena S, Ortega A, Estrela JM, Mutat Res 2009 674 36 44 18977455
43. Singlet oxygen induced DNA damage and mutagenicity in a single-stranded SV40-based shuttle vector. Ribeiro DT, Madzak C, Sarasin A, DI Mascio P, Sies H, Menck CFM, Photochem Photobiol 1992 55 39 45 10.1111/j.1751-1097.1992.tb04207.x 1318549
44. Spiroiminodihydantoin lesions derived from guanine oxidation: structures, energetics, and functional implications. Jia L, Shafirovich V, Shapiro R, Geacintov NE, Broyde S, Biochemistry 2005 44 Suppl 16 6043 6051 15835893 (Pubitemid 40570698)
45. The Nordic profile of skin cancer incidence. A comparative epidemiological study of the three main types of skin cancer. Magnus K, Int J Cancer 1991 47 12 19 10.1002/ijc.2910470104 1985867
46. Mutations of the BRAF gene in human cancer. Davies H, Bignell GR, Cox C, Nature 2002 417 949 954 10.1038/nature00766 12068308 (Pubitemid 34716871)
47. Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive meta-analysis. Dennis LK, Vanbeek MJ, Beane LE Freeman, Smith BJ, Dawson DV, Coughlin JA, Ann Epidemiol 2008 18 Suppl 8 614 627 18652979 (Pubitemid 352001390)
48. Protection factor of sunscreens to monochromatic radiation. Cripps DJ, Hegedus S, Arch DenmatoL 1974 7 202 204
49. Sunburn and paraaminobenzoic acid. Rothman S, Rubin J, J Invest Dermatol 1942 5 445 457 10.1038/jid.1942.59
50. Aminobenzoic acid and its esters: the quest for more effective sunscreens. Willis I, Kligmnan AM, ArchDermatoL 1970 102 405 417
51. Sunscreens - what's important to know. Antoniou C, Kosmadaki MG, Stratigos AJ, Katsambas AD, J Eur Acad Dermatol Venereol 2008 22 1110 1118 18482317
52. Sunscreen enhancement of UV-induced reactive oxygen species in the skin. Hanson KM, Gratton E, Bardeen CJ, Free Radical Biol Med 2006 41 Issue 8 1205 1212 (Pubitemid 44466318)
53. Sun Protection in Man. Cantrell A, McGarvey, David J, Comprehensive Series in Photosciences Elsevier 2001 495 497 519
54. DNA Damage Photoinduced by Titanium Dioxide in the Presence of Anionic Vesicles under UV Illumination: Influence of Sodium Chloride Concentration. Arsac F, Hisao H, Journal of Oleo Science 2007 56 595 601 10.5650/jos.56.595 17938550
55. DNA Damage Photoinduced by Cosmetic Pigments and Sunscreen Agents under Solar Exposure and Artificial UV Illumination. Hidaka H, Kobayashi H, Koike T, Sato T, Serpone N, Journal of Oleo Science 2006 55 249 261 10.5650/jos.55.249
56. Perspectives in melanoma prevention: the case of sunbeds. Autier P, Eur J Cancer 2004 40 2367 10.1016/j.ejca.2004.07.018 15519507 (Pubitemid 39424948)
57. Lack of in vitro protection by a common sunscreen ingredient on UVA-induced cytotoxicity in keratinocytes. Armeni T, Damiani E, Battino M, Greci L, Principato G, Toxicol 2004 203 165 178 10.1016/j.tox.2004.06.008 (Pubitemid 39200947)
58. Sunlight-induced mutagenicity of a common sunscreen ingredient [abstract]. Knowland J, McKenzie EA, McHugh PJ, Cridland NA, FEBS Letters 1993 324 309 313 10.1016/0014-5793(93)80141-G (Pubitemid 23172150)
59. Photosensitization of the Sunscreen Octyl p-Dimethylaminobenzoate b UVA in Human Melanocytes but not in Keratinocytes. Xu C, Green A, Parisi A, Parsons PG, Photochem Photobiol 2001 73 600 604 10.1562/0031-8655(2001)073<0600: POTSOP>2.0.CO;2 11421064
60. Stripping method to quantify absorption of two sunscreens in human. Couteau C, Perez N Cullel, Connan AE, Coiffard LJM, Int J Pharm 2001 222 153 157 10.1016/S0378-5173(01)00674-3 11404041 (Pubitemid 32525796)
61. Differentiated in vivo skin penetration of salicylic compounds in hairless rats measured by cutaneous microdialysis. Simonsen L, Jørgensen A, Benfeldt E, Grotha L, Eur J Pharmaceut Sci 2004 21 379 388 10.1016/j.ejps.2003.11.004 (Pubitemid 38156176)
62. Percutaneous absorption of zinc from zinc oxide applied topically to intact skin in man [abstract]. Agren MS, Dermatologica 1990 180 36 39 10.1159/000247982
63. Veterinary drug delivery: potential for skin penetration enhancement. Magnusson BM, Kenneth A, Walters KA, Roberts MS, Adv Drug Deliv Rev 2001 50 205 227 10.1016/S0169-409X(01)00158-2 11500228 (Pubitemid 32735457)
64. Microemulsion for Intradermal Delivery Of Cetyl Alcohol and Octyl Dimethyl PABA. Linn EE, Pohland RC, Byrd TK, Drug Dev Ind Pharm 1990 16 899 920 10.3109/03639049009114917 (Pubitemid 20147811)
65. Percutaneous absorption of organic sunscreens. Varvaresou A, J Cosmet Dermatol 2006 5 53 57 10.1111/j.1473-2165.2006.00223.x 17173572
66. Assessment and Clinical Implications of Absorption of Sunscreens Across Skin. Benson HAE, Am J Clin Dermatol 2000 1 217 224 10.2165/00128071-200001040- 00003 11702366
67. Nitroxide radicals protect DNA from damage when illuminated in vitro in the presence of dibenzoylmethane and a common sunscreen ingredient. Damiani E, Greci L, Parsons R, Knowland J, Free Radic Biol Med 1999 26 809 816 10.1016/S0891-5849(98)00292-5 10232823 (Pubitemid 29198352)
68. Could sunscreens increase melanoma risk? Garland C, Garland F, Gorham E, Am J Public Health 1992 82 614 615 10.2105/AJPH.82.4.614 1546792
69. Sunscreen use and malignant melanoma. Westerdahl J, Ingvar C, Masback A, Olsson H, Int J Cancer 2000 87 145 150 10861466 (Pubitemid 30368429)
70. Do sunscreens increase or decrease melanoma risk: An epidemiologic evaluation. Weinstock MA, J Investig Dermatol Symp Proc 1999 4 97 100 10537017 (Pubitemid 29491264)
71. Cancer-preventive effects of sunscreens are uncertain. Vainio H, Bianchini F, Scand J Work Environ Health 2000 26 529 531 10.5271/sjweh.578 11201401 (Pubitemid 32051439)
72. Sunscreens: Safety, Efficacy and Appropriate Use. Moloney FJ, Collins S, Murphy GM, Am J Clin Dermatol 2002 3 185 191 10.2165/00128071-200203030-00005 11978139 (Pubitemid 34533778)
73. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population. Rádenas JM, Delgado-Rodríguez M, Herranz MT, Tercedor J, Serrano S, Canc Causes Contr 1996 7 275 283 10.1007/BF00051303 (Pubitemid 26155464)
74. Cutaneous malignant melanoma and sun exposure in Spain [abstract]. Espinosa J Arranz, Sanchez JJ Hernandez, Bravo P Fernandez, Gonzalez-Baron M, Zamora P Aũon, Espinosa E Arranz, Jalon JI Lopez, Ordõez A Gallego, Melanoma Res 1999 9 199 205 10.1097/00008390-199904000-00013 (Pubitemid 29331529)
75. Drug-induced cutaneous photosensitivity. Moore DE, Drug Saf 2002 25 345 372 10.2165/00002018-200225050-00004 12020173
76. Drug-induced photosensitivity. Allen JE, Clin Pharm 1993 12 580 587 8222522 (Pubitemid 23213473)
77. Evaluation of UV-radiation induced singlet oxygen generation potential of selected drugs. Pandey R, Mehrotra S, Ray RS, Joshi PC, Hans RK, Drug Chem Toxicol 2002 25 215 225 10.1081/DCT-120003261 12024804 (Pubitemid 34475651)
78. UVA photoirradiation of retinyl palmitateFormation of singlet oxygen and superoxide, and their role in induction of lipid peroxidation. Xiaa Q, Yin JJ, Cherng SH, Wamer WG, Boudreau M, Howard PC, Fu PP, Toxicol Lett 2006 163 30 43 10.1016/j.toxlet.2005.09.010 16384671 (Pubitemid 43356617)
79. Mechanism of UVA-dependent DNA Damage Induced by An Antitumor Drug Dacarbazine in Relation to its Photogenotoxicity. Iwamoto T, Hiraku Y, Okuda M, Kawanishi S, Pharmaceut Res 2008 25 598 604 10.1007/s11095-007-9413-2 (Pubitemid 351357730)
80. Azathioprine and UVA Light Generate Mutagenic Oxidative DNA Damage. O'Donovan P, Perrett CM, Zhang X, Montaner B, Xu Y-Z, Harwood CA, McGregor JM, Walker SL, Hanaoka F, Karran P, Science 2005 309 1871 1874 10.1126/science. 1114233 16166520 (Pubitemid 41325100)
81. Adverse Drug Reactions. 2nd edtition. Lee A, Thomson J, Pharmaceutical Press 2006 143 145
82. The Safe Shopper's Bible. A Consumer's Guide to Nontoxic Household Products, Cosmetics, and Food. Steinma D, Epstein S, New York: MacMillan 1995
83. Under the skin: Biotransformation of para-aminophenol and para-phenylenediamine in reconstructed human epidermis and human hepatocytes. Nohynek GJ, Ducheb D, Garrigues A, Meunier P-A, Toutaina H, Leclaire J, Toxicol Lett 2005 158 196 212 10.1016/j.toxlet.2005.03.014 15890478 (Pubitemid 41074816)
84. Carcinogenicity of an oxidation product of p-phenylenediamine. Rojanapo W, Piangchai K, Anong T, Sopa M Chutimataewin, Tanyakaset M, Carcinogenesis 1986 7 1997 2002 10.1093/carcin/7.12.1997 3779896
85. Toxicity and human health risk of hair dyes. Nohynek GJ, Fautz R, Benech-Kieffer F, Toutain H, Food Chem Toxicol 2004 42 517 543 10.1016/j.fct.2003.11.003 15019177 (Pubitemid 38314824)
86. Photochemical and thermal modifications of permanent hair dyes. Motz-Schalck L, Lemaire J, J Photochem Photobiol Chem 2002 147 225 223 10.1016/S1010-6030(01)00617-7
87. Final Report on the Safety Assessment of Melamine/Formaldehyde Resin. Andersen FA, Int J Toxicol 1995 14 373 385 10.3109/10915819509083598
88. UV doses worldwide. Photochem. Godar DE, Photobiol 2005 81 4 736 49
89. Proportion of lifetime UV dose received by children, teenagers and adults based on time-stamped personal dosimetry. Thieden E, Philipsen PA, Sandby-Møller J, Heydenreich J, Wulf HC, J Invest Dermatol 2004 123 1147 1150 10.1111/j.0022-202X.2004.23466.x 15610527 (Pubitemid 39586839)
90. Melanoma and exposure to sunlight. Lee JAH, Epidemiol Rev 1982 4 110 136 6754404 (Pubitemid 13249676)
91. Melanoma and other tumors of the skin among office, othe indoor, and outdoor workers in Sweden 1961-1979. Vagero D, Ringback G, Kiveranta H, Brit J Cancer 1986 53 507 512 10.1038/bjc.1986.80 3707844 (Pubitemid 16111968)
92. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. Kennedy C, Bajdik CD, Willemze R, De Gruijl FR, Bouwes JN Bavinck, J Invest Dermatol 2003 120 1087 1093 10.1046/j.1523-1747.2003.12246.x 12787139 (Pubitemid 36702922)
93. The indoor UV tanning industry: A review of skin cancer risk, health benefit claims, and regulation. Levine JA, Sorace M, Spencer J, Siegel DM, J Am Acad Dermatol 2005 53 1038 1044 10.1016/j.jaad.2005.07.066 16310065 (Pubitemid 41677329)
94. Increased UVA exposures and decreased cutaneous Vitamin D3 levels may be responsible for the increasing incidence of melanoma. Godar DE, Robert J, Landry A, Lucas AD, Med Hypotheses 2009 72 434 443 10.1016/j.mehy.2008.09.056 19155143
95. Indoor ultraviolet tanning: what the data do and do not show regarding risk of melanoma and keratinocyte malignancies. Weinstock MA, Fisher DE, J Natl Compr Canc Netw 2010 8 867 873 20870632
96. Tanning beds, sunlamps, and risk of cutaneous malignant melanoma. Gallagher RP, Spinelli JJ, Lee TK, Cancer Epidemiol Biomarkers Prev 2005 14 562 566 10.1158/1055-9965.EPI-04-0564 15767329 (Pubitemid 40489195)
97. Prevalence and correlates of indoor tanning among US adults. Heckman CJ, Coups EJ, Manne SL, J Am Acad Dermatol 2008 58 769 780 10.1016/j.jaad.2008.01. 020 18328594
98. Beware the A-ray. Marshall Jessica, The New Scientist Volume 2007 194 Issue 2610 38 41 (Pubitemid 46977522)
99. Melanoma and use of sunscreens: An EORTC case control study in Germany, Belgium and France. Autier P, Dore JF, Schifflers E, Cesarini JP, Bollaerts A, Koelmel KF, Gefeller O, Liabeuf A, Lejeune F, Lienard D, Int. J. Cancer 1995 61 749 755 10.1002/ijc.2910610602 7790106
100. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review. Kroft EB, Berkhof NJ, van de Kerkhof PC, Gerritsen RM, de Jong EM, J Am Acad Dermatol 2008 59 1017 1030 10.1016/j.jaad.2008.07.042 18835066
101. Guideline for the diagnosis and management of vitiligo. Gawkrodger DJ, Ormerod AD, Shaw L, Mauri-Sole I, Whitton ME, Watts MJ, Anstey AV, Ingham J, Young K, Br J Dermatol 2008 159 1051 1076 10.1111/j.1365-2133.2008.08881.x 19036036
102. Phototherapy and photochemotherapy: an update. Morison WL, Semin Cutan Med Surg 1999 18 297 306 10.1016/S1085-5629(99)80029-7 10604796
103. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin. Wetzig T, Sticherling M, Simon J-C, Hegenbart U, Niederwieser D, Al-Ali HK, Bone Marrow Transplant 2005 35 515 519 10.1038/sj.bmt.1704804 15665847 (Pubitemid 40403356)
104. Photochemotherapy. Lauharanta J, Clin Dermatol 1997 15 769 780 10.1016/S0738-081X(97)00015-1 9313975 (Pubitemid 27411308)
105. Photo (chemo) therapy: general principles. Lowe NJ, Chizhevsky V, Gabriel H, Clin Dermatol 1997 15 745 752 10.1016/S0738-081X(97)00017-5 9313973 (Pubitemid 27411306)
106. The PUVA Follow up Study, The risk of melanoma in association with long-term exposure to PUVA. Stern RS, J Am Acad Dermatol 2001 44 755 761 10.1067/mjd.2001.114576 11312420 (Pubitemid 32391161)
107. Melanoma and ionizing radiation: is there a causal relationship? Fink CA, Bates MN, Radiat Res 2005 164 701 710 10.1667/RR3447.1 16238450 (Pubitemid 41532568)
108. Endocrine factors as effectors of integumental pigmentation. Abdel-Malek ZA, Dermatol Clin 1988 6 175 183 3132340
109. Sunbelt Melanoma Trial: Gender-Related Differences in Outcome for Melanoma Patients. Scoggins CR, Merrick IR, Douglas S, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Edwards MJ, Chagpar AB, Martin RCG, Stromberg AJ, Hagendoorn L, McMasters KM, Ann Surg 2006 243 693 700 10.1097/01.sla.0000216771.81362.6b 16633005
110. Melanoma in children and teenagers: An analysis of patients from the National Cancer Data Base. Lange JR, Palis BE, Chang DC, Soong S-J, Balch CM, J Clin Oncol 2007 25 1363 1368 10.1200/JCO.2006.08.8310 17416855 (Pubitemid 46706883)
111. Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study. Koomen ER, Joossel A, Herings RMC, Casparie MK, Guchelaar HJ, Nijsten T, Ann Oncol 2009 20 358 364 18725391
112. Sex steroid receptor analysis in human melanoma. McCarty KS Jr, Wortman J, Stower SS, Lugahn DB, McCarty KS Sr, Seigler HF, Cancer 1980 46 1463 1470 6774805 (Pubitemid 11253536)
113. Donor Specific Response of Estrogen and Progesterone on Cultured Human Melanocytes. Im S, Lee ES, Kim W, On W, Kim J, Lee M, Kang WH, J Korean Med Sci 2002 17 58 64 11850590
114. Biological activity and binding of estradiol to SK-Mel 23 human melanoma cells. Sarti M, Visconti MA, Castrucci AML, Braz J Med Biol Res 2004 37 901 905 10.1590/S0100-879X2004000600016 15264034 (Pubitemid 38811986)
115. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL Jr, Anton-Culver H, J Clin Oncol 2008 26 66 75 10.1200/JCO.2007.12.3604 18165642
116. Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Konstantinos L, Leiter U, Meier F, Eigentler T, Metzler G, Moehrle M, Breuninger H, Garbe C, Cancer 2008 112 No. 8 1795 1780 10.1002/cncr.23359 18306371 (Pubitemid 351536840)
117. Cancer and pregnancy. Pavlidis N, Ann Oncol 2000 11 247 255 11079149
118. Coexistence of pregnancy and malignancy. Pavlidis NA, The Oncologist 2002 7 279 287 12185292 (Pubitemid 34919954)
119. Cancer statistics, 2003. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ, CA Cancer J Clin 2003 53 5 26 10.3322/canjclin.53.1.5 12568441 (Pubitemid 36163619)
120. Melanoma and pregnancy. Driscoll MS, Grant-Kels JM, G Ital Dermatol Venereol 2008 143 251 257 18833081
121. Malignant melanoma in pregnancy. A population-based evaluation. O'Meara AT, Cress R, Xing G, Danielsen B, Smith LH, Cancer 2005 103 1217 1226 10.1002/cncr.20925 15712209 (Pubitemid 40328093)
122. Effect of Pregnancy on Survival in Women With Cutaneous Malignant Melanoma. Lens MB, Rosdahl I, Ahlbom A, Farahmand BY, Synnerstad I, Boeryd B, Newton JA Bishop, Am J Clin Oncol 2004 22 No 21 4369 4375 10.1200/JCO.2004.02. 096 (Pubitemid 41185157)
123. Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues. Lens M, Bataille V, Canc Causes Contr 2008 19 437 442 10.1007/s10552-008-9110-4
124. Malignant melanoma and pregnancy. Silipo V, De Simone P, Mariani G, Buccini P, Ferrari A, Catricala C, Melanoma Res 2006 16 497 500 10.1097/01.cmr.0000232295.91536.09 17119450 (Pubitemid 44934707)
125. Pregnancy history and incidence of melanoma in women: a pooled analysis. Karagas MR, Zens MS, Stukel TA, Swerdlow AJ, Rosso S, Osterlind A, Mack T, Kirkpatrick C, Holly EA, Green A, Gallagher R, Elwood JM, Armstrong BK, Canc Causes Contr 2006 17 11 19 10.1007/s10552-005-0281-y (Pubitemid 43083665)
126. Does pregnancy alter melanocytic nevi? Grin CM, Rojas AI, Grant-Kels JM, J Cutan Pathol 2001 28 389 392 10.1034/j.1600-0560.2001.028008389.x 11493375 (Pubitemid 32756575)
127. Analysis of melanocytic naevi by dermoscopy during pregnancy. Gunduz K, Koltan S, Sahin MT, Filiz E, J Eur Acad Dermatol Venereol 2003 17 349 351 10.1046/j.1468-3083.2003.00792-2.x 12702085 (Pubitemid 36575667)
128. Focus on primary care: from nevus to neoplasm: myths of melanoma in pregnancy. Katz VL, Farmer RM, Dotters D, Obstet Gynecol Surv 2002 57 112 119 10.1097/00006254-200202000-00023 11832787 (Pubitemid 34132149)
129. Cell cycle block and apoptosis induction in a human melanoma cell line following treatment with 2-methoxyoestradiol: therapeutic implications? Ghosh R, Ott AM, Seetharam D, Slaga T, Kumar AP, Addanki P, Melanoma Res 2003 13 119 127 10.1097/00008390-200304000-00003 12690294 (Pubitemid 36583973)
130. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families. Chaudru V, Chompret A, Bressac-de Paillerets B, Spatz A, Avril MF, Demenais F, J Natl Cancer Inst 2004 96 785 795 10.1093/jnci/djh136 15150307 (Pubitemid 38771824)
131. Melasma: a review. Victor FC, Gelber J, Rao B, J Cutan Med Surg 2004 8 97 102 15685388 (Pubitemid 38781362)
132. Melasma: histopathological characteristics in 56 Korean patients. Kang WH, Yoon KH, Lee ES, Kim J, Lee KB, Yim H, Sohn S, Im S, Br J Dermatol 2002 146 228 237 10.1046/j.0007-0963.2001.04556.x 11903232 (Pubitemid 34264392)
133. Effect of melasma on quality of life in a sample of women living in southern Brazil. Freitag FM, Cestari TF, Leopoldo LR, Paludo P, Boza JC, J Eur Acad Dermatol Venereol 2007 22 655 662
134. The Correlation between melasma, ovarian cysts and androgenic hormones (a case control study). Adalatkhan H, Amani F, Res Biol Sci 2007 2 593 596
135. Hyperpigmentation: An Overview of the Common Afflictions. Cayce KA, McMichael AJ, Feldman SR, Dermatol Nurs 2004 16 401 416 15624705
136. Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma. Grimes PE, Yamada N, Bhawan J, Am J Dermatopathol 2005 27 96 101 10.1097/01.dad.0000154419.18653.2e 15798432 (Pubitemid 40471093)
137. Pigmentary demarcation lines of pregnancy. Amichaia B, Grunwald MH, Eur J Obstet Gynecol Reprod Biol 2007 131 239 240 10.1016/j.ejogrb.2006.04.030 16730876 (Pubitemid 46452899)
138. The Skin in Pregnancy. Barankin B, Silver SG, Carruthers A, J Cutan Med Surg 2002 6 236 240 10.1007/s10227-001-0045-6 11951128 (Pubitemid 34839934)
139. Melanosis of the areola and nipple. Sceppa JA, Smith BL, Marghoob AA, Gottlieb GJ, J Am Acad Dermatol 2008 59 Suppl 1 33 S34 18625375
140. Effects of estrogens on human melanocytes in vitro. McLeod SD, Ranson M, Mason RS, J Steroid Biochem Mol Biol 1994 49 9 14 10.1016/0960-0760(94)90295-X 8003445 (Pubitemid 24219204)
141. Estrogen receptor expression in melasma: results from facial skin of affected patients. Lieberman R, Moy L, J Drugs Dermatol 2008 7 463 465 18505139
142. Physiological changes in the skin during pregnancy. Elling SV, Powell FC, Clin Dermatol 1997 15 35 43 10.1016/S0738-081X(96)00108-3 9034654 (Pubitemid 27082287)
143. Dermatoses of pregnancy. Winton GB, Lewis CW, J Am Acad Dermatol 1982 6 977 998 10.1016/S0190-9622(82)70083-0 7047596 (Pubitemid 12116361)
144. Skin diseases in pregnancy. Black MM, Wilkinson JD, In Principles and Practice of Obstetrics and Perinatology Philadelhia, John Wiley, 1987 136 179
145. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. Sanchez NP, Pathak MA, Sato S, Fitzpatrick TB, Sanchez JL, Mihm MC Jr, J Am Acad Dermatol 1981 4 698 710 10.1016/S0190-9622(81)70071-9 6787100 (Pubitemid 11038002)
146. Melasma: insights and perspectives. Jadotte YT, Schwartz RA, Acta Dermatovenerol Croat 2010 18 124 129 20624364
147. Management of Facial Hyperpigmentation. Disease Management. Perez-Bernal A, Munoz-Perez MA, Camacho F, Am J Clin Derm 2000 1 261 268 10.2165/00128071- 200001050-00001
148. Dermatology in General Medicine. Fitzpatrick TB, Eisen AZ, Wolff K, Freedburg IM, Frank AK, Mcgraw-Hill 1993 996 997
149. Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus): homozygous deletions and mutations in the p16 and p14ARF genes in sporadic primary melanomas. Kumar R, Smeds J, Lundh B Rozell, Hemminki K, Melanoma Res 1999 9 138 147 10.1097/00008390-199904000-00005 10380936 (Pubitemid 29331522)
150. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families. Chaudru V, Chompret A, Bressac-de Paillerets B, Spatz A, Avril MF, Demenais F, J Natl Cancer Inst 2004 96 785 795 10.1093/jnci/djh136 15150307 (Pubitemid 38771824)
151. Familial cutaneous melanoma. Hansson J, Adv Exp Med Biol 2010 685 134 145 10.1007/978-1-4419-6448-9-13 20687502
152. Melanoma Genetics Consortium: Geographical variation in the penetrance of CDKN2A mutations for melanoma. Bishop DT, Demenais F, Goldstein AM, Bergman W, Bishop JN, Bressac-de Paillerets B, Chompret A, Ghiorzo P, Gruis N, Hansson J, Harland M, Hayward N, Holland EA, Mann GJ, Mantelli M, Nancarrow D, Platz A, Tucker MA, J Natl Cancer Inst 2002 94 894 903 10.1093/jnci/94.12.894 12072543 (Pubitemid 34778088)
153. Melanoma genetics: an update on risk-associated genes. Udayakumar D, Tsao H, Hematol Oncol Clin North Am 2009 23 415 429 10.1016/j.hoc.2009.03.011 19464594
154. Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk. Di Lucca J, Guedj M, Lacapère JJ, Fargnoli MC, Bourillon A, Dieudé P, Dupin N, Wolkenstein P, Aegerter P, Saiag P, Descamps V, Lebbe C, Basset-Seguin N, Peris K, Grandchamp B, Soufir N, Eur J Cancer 2009 45 3228 3236 10.1016/j.ejca.2009.04.034 19477635
155. DNA repair gene polymorphisms and risk of cutaneous melanoma: a systematic review and meta-analysis. Mocellin S, Verdi D, Nitti D, Carcinogenesis 2009 30 1735 43 10.1093/carcin/bgp207 19706646
156. DNA repair pathways and human metastatic malignant melanoma. Sarasin A, Dessen P, Curr Mol Med 2010 10 413 418 10.2174/156652410791317011 20455851
157. Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: a systematic review and meta-analysis. Mocellin S, Nitti D, Cancer 2008 113 2398 2407 10.1002/cncr.23867 18816636
158. Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Randerson-Moor JA, Taylor JC, Elliott F, Chang YM, Beswick S, Kukalizch K, Affleck P, Leake S, Haynes S, Karpavicius B, Marsden J, Gerry E, Bale L, Bertram C, Field H, Barth JH, Silva ID, Swerdlow A, Kanetsky PA, Barrett JH, Bishop DT, Bishop JA, Eur J Cancer 2009 45 3271 81 10.1016/j.ejca.2009.06.011 19615888
159. MC1R Genotype modifies risk of mealnoma in families segregating CDKN2A mutations. Box NF, Duffy DL, Chen W, Stark M, Martin NG, Sturm RA, Hayward NK, Am J Hum Genet 2001 69 765 773 10.1086/323412 11500805 (Pubitemid 32868521)
160. MC1R Germline Variants Confer Risk for BRAF-Mutant Melanoma. Landi MT, Bauer J, Pfeiffer RM, Elder DE, Hulley B, Minghetti P, Calista D, Kanetsky PA, Pinkel D, Bastian BC, Science 2006 313 521 522 10.1126/science.1127515 16809487 (Pubitemid 44148456)
161. BRAF Mutations in Metastatic Melanoma A Possible Association with Clinical Outcome. Kumar R, Clin Canc Res 2003 9 3362 3368 (Pubitemid 37082731)
162. MC1R variants associated susceptibility to basal cell carcinoma of skin: Interaction with host factors and XRCC3 polymorphism. Scherer D, Bermejo JL, Rudnai P, Gurzau E, Koppova K, Hemminki K, Kumar R, Int J Cancer 2008 122 1787 1793 18067130 (Pubitemid 351413425)
163. Final Amended Report on the Safety Assessment of Oxyquinoline and Oxyquinoline Sulfate as Used in Cosmetics. Cosmetic Ingredient Review (CIR) Expert Panel, Int J Toxicol 2006 25 1 9 17090479
164. Final report on the safety assessment of benzoxiquine. Cosmetic Ingredient Review Expert Panel, Int J Toxicol 1997 16 Suppl 1 117 122
165. Secretariat for The Vienna Convention for the Protection of the Ozone Layer & The Montreal Protocol on Substances that Deplete the Ozone Layer. The Montreal Protocol on Substances that Deplete the Ozone Layer, 2000 1 47